[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$vani
$vani sees a surge in social media engagement, driven by positive research and market expansion. However, concerns about side effects and costs persist, creating a mixed outlook.
About $vani
Analysis of social media data and insights on the pharmaceutical industry, specifically focusing on the drug $vani.
Insights #
- $vani creators is up XXXXXXXX% from the previous month.
- $vani engagements is up XXXXXXXX% from the previous week.
- $vani mentions is up XXXXXXXX% from the previous month.
- $vani posts created is up XXXXXXXX% from the previous week.
- $vani Engagements hit a high of XXXXXX for the day
- $vani Engagements hit an all time of XXXXXX for the day
Engagements: XXXXXX #
Engagements 24-Hour Chart Data
Current Value: XXXXXX
Daily Average: XXXXX
1 Week: XXXXXX +2,355%
1 Month: XXXXXXX +571%
1-Year High: XXXXXX on 2025-07-17
1-Year Low: X on 2025-04-27
| Social Network | X |
|---|---|
| Engagements | XXXXXX |
Mentions: XXX #
Mentions 24-Hour Chart Data
Current Value: XXX
Daily Average: XX
1 Week: XXX +101%
1 Month: XXXXX +1,005%
1-Year High: XXX on 2025-06-27
1-Year Low: X on 2025-04-27
| Social Network | X |
|---|---|
| Mentions | XXX |
Creators: XX #
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning $vani in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
1 Week: XX +22%
1 Month: XXX +5,409%
1-Year High: XXX on 2025-06-27
1-Year Low: X on 2025-04-27
The most influential creators that mention $vani in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @AponiaAnalytics | X | XXXXX | XX | XXXXX |
Sentiment: XX% #
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -XX%
1 Month: XX% -XX%
1-Year High: XXX% on 2025-06-11
1-Year Low: XX% on 2025-07-23
Most Supportive Themes
- Cardiometabolic Benefits: (30%) Positive outcomes associated with GLP-1 receptor agonist therapy, including improved cardiometabolic outcomes, weight loss, and reduced risk of heart disease.
- Hormonal and Sleep Benefits: (15%) The potential of GLP-1 drugs to boost testosterone levels in men and improve sleep quality, leading to better weight loss results.
- Market Expansion: (10%) The expansion of Hims & Hers into Canada and the availability of Wegovy in Singapore, indicating market growth and accessibility.
- New Research and Developments: (5%) The emergence of new research and developments in GLP-1 therapies, including oral medications and gene editing approaches.
Most Critical Themes
- GLP-1 Drug Risks: (23%) Concerns about risks and side effects of GLP-1 drugs, including potential for optic nerve damage, gastroesophageal reflux disease, and mental health issues.
- Cost and Economic Concerns: (10%) Criticism of the high cost and economic inefficiency of GLP-1 drugs, particularly in the context of Medicare coverage.
- Unsupervised Use and Misleading Practices: (5%) Warnings against unsupervised use of weight-loss drugs and the potential for misleading advertising and pricing practices.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXXXX | XX% | XXXXX | XX% | XXXXX | XX% |
| Total | XXXXX | XX% | XXXXX | XX% | XXXXX | XX% |
Top assets mentioned In the posts about $vani in the last XX hours
Hims & Hers Health, Inc. (HIMS) Biogen Inc (BIIB) GSK plc (GSK) cuh (CUH) First Convicted RACOON (FRED) Solana (SOL) Solana (SOL) Bytom (BTM) Lucid Group Inc (LCID) Veritaseum (VERI)
Top topics mentioned In the posts about $vani in the last XX hours
manat, $hims, hims, pfe, $zldpf, $biib, $wwb, $gsk, $rhhby, telo, dtc, sis, gem, $viot, mira, pltr, $vrax, $cuh, $fred, coins solana ecosystem, op, coins meme, new era, sol, $sol, solana, coins layer 1, bruv, $bruv, $elrrf, $biov, $govx, valentine, arc, ras, the worlds, $btm, $stem, $lcid, $vvpr, $veri, amzn, gibraltar pound, patience, $ixhl, $sis, usduc, pep, axr, bch, srm, $quad, $tmp, sonn, $vmeo, $aacg, $wafdp, nmr, $cars, $nmr, $sjm, $asgi, spy, bti, bnt, $uuuu, tnk, $bpypp, $gryp, $tnk, $crgo, $tci, $scsc, $vnrx, $zenv, sho, $rent, tesla, stocks consumer cyclical, stocks bitcoin treasuries, sre, qqq, spx, $tfx, $cste, poop, $poop, plag, $ribbu, $mbi, $sowg, $ilpt, $coll, $fmnb, $inbkz, dawg, $dumb, $dawg, $belfb, $rhi
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"🦉 Liraglutide in teens with T2D: XXX mg/day over XX weeks cut HbA1c by XXX% while weight dropped XXX kg. Ages 1018. Studied with background metformin. #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"
@AponiaAnalytics on X 2025-07-23 00:22:27 UTC 4968 followers, XXX engagements
"🦉 Cagrilintide alone got people to XXX% weight loss in X months. Now paired with semaglutide in the CagriSema comboPhase X trials are aiming for 20%. #GLP1 #weightloss $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"
@AponiaAnalytics on X 2025-07-23 00:20:52 UTC 4968 followers, XXX engagements
"🦉 UK vs. Nordic data on GLP-1RA and bowel obstruction dont align. UK: XX% higher risk. Nordic registry No difference seen between GLP-1RA and SGLT2i users. #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"
@AponiaAnalytics on X 2025-07-23 00:20:36 UTC 4968 followers, XXX engagements
"🦉 STEP 2: In T2D semaglutide XXX mg weekly delivered XXX% placebo-subtracted weight loss in XX weeks. Less than what non-diabetic patients typically lose. #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"
@AponiaAnalytics on X 2025-07-23 00:20:19 UTC 4968 followers, XXX engagements